Stephen P. Carey - Feb 12, 2025 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SVP & CFO
Signature
/s/ Stephen P. Carey, by attorney-in-fact Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Feb 12, 2025
Transactions value $
-$101,932
Form type
4
Date filed
2/18/2025, 08:11 PM
Previous filing
Dec 18, 2024
Next filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Award $0 +24.8K +16.06% $0.00 179K Feb 12, 2025 Direct F1
transaction ANIP Common Stock Award $0 +16.5K +9.22% $0.00 196K Feb 12, 2025 Direct F2
transaction ANIP Common Stock Tax liability -$102K -1.73K -0.88% $58.92 194K Feb 14, 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025.
F2 These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.
F3 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 5,368 shares of restricted stock, the grant of which was previously reported.